Evidence map›Paper›PMID 28732836›Full record

ArticleRespiratory medicine2017

Adherence and healthcare utilization among older adults with COPD and depression.

Jennifer S Albrecht, Bilal Khokhar, Ting-Ying Huang, Yu-Jung Wei, Ilene Harris, Patience Moyo, Peter Hur, Susan W Lehmann, Giora Netzer, Linda Simoni-Wastila

Abstract readComparative Study
In one paragraph

Article in Respiratory medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Methods to assess COPD medications adherence in healthcare databases: a systematic review.European respiratory review : an official journal of the European Respiratory Society · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Definition of treatment-resistant late-life depression: Conclusions from a European Task Force Delphi process.European psychiatry : the journal of the Association of European Psychiatrists · 2026
    Article
  7. Review
  8. Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting βInternational journal of chronic obstructive pulmonary disease · 2023
    Article
  9. Observational
  10. Article
  11. Article
  12. Article
  13. Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.International journal of chronic obstructive pulmonary disease · 2020
    Article
  14. Observational
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jennifer S AlbrechtDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, United States.
Bilal KhokharDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, United States.
Ting-Ying HuangDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, United States.
Yu-Jung WeiDepartment of Pharmaceutical Outcomes and Policy, University of Florida College of Pharmacy, United States.
Ilene HarrisIMPAQ International LLC, Columbia, MD, United States.
Patience MoyoDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, United States.
Peter HurDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, United States.
Susan W LehmannDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, United States.
Giora NetzerDepartment of Epidemiology and Public Health, University of Maryland School of Medicine, United States; Division of Pulmonary and Critical Care Medicine, University of Maryland School of Medicine, United States.
Linda Simoni-WastilaDepartment of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, United States. Electronic address: lsimoniw@rx.umaryland.edu.

Funding

University of Florida Older Americans Independence Center (OAIC)P30AG028740 · NIA · UNIVERSITY OF FLORIDA · PI Karyn A Esser, Todd Manini · 2007 to 2026
$22.8M
RESEARCH TRAINING IN THE EPIDEMIOLOGY OF AGINGT32AG000262 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI ANN L GRUBER-BALDINI, DENISE L ORWIG · 1998 to 2026
$8.2M
Prioritizing Quality Improvement for the Treatment of Psychiatric Disturbances Following Traumatic Brain InjuryK01HS024560 · AHRQ · UNIVERSITY OF MARYLAND BALTIMORE · PI ALBRECHT, JENNIFER S. · 2016 to 2020
$735k
COPD Treatment in Older Adults with DepressionR21AG045573 · NIA · UNIVERSITY OF MARYLAND BALTIMORE · PI SIMONI-WASTILA, LINDA J · 2013 to 2014
$422k
AHRQ HHS K01 HS024560NIA NIH HHS P30 AG028740NIA NIH HHS R21 AG045573NIA NIH HHS T32 AG000262
6 · The paper itself

Abstract

BACKGROUND AND

objectiveAdherence to chronic obstructive pulmonary disease (COPD) maintenance medications and antidepressants may reduce healthcare utilization among multimorbid individuals with COPD and depression. We quantified the independent effects of adherence to antidepressants and COPD maintenance medications on healthcare utilization among individuals co-diagnosed with COPD and depression. PROCEDURES: We conducted a retrospective cohort study using a 2006-2012 5% random sample of Medicare beneficiaries co-diagnosed with COPD and depression who had two or more prescription fills of both COPD maintenance medications and antidepressants. We measured adherence to medications using the proportion of days covered per 30-day period. The primary outcomes were all-cause emergency department (ED) visits and hospitalizations. Beneficiaries were followed over a minimum 12-month follow-up period.

resultsOf the 16,075 beneficiaries meeting inclusion criteria, 21% achieved adherence ≥80% to COPD maintenance medications and 55% achieved adherence ≥80% to antidepressants. Compared to no use and controlling for antidepressant adherence and potential confounders, higher (≥80%) levels of adherence to COPD maintenance medications were associated with decreased risk of ED visits (hazard ratio (HR) 0.79; 95% CI 0.74, 0.83) and hospitalizations (HR 0.82; 95% CI 0.78, 0.87). Similarly, higher levels (≥80%) of adherence to antidepressants resulted in decreased risk of ED visits (HR 0.74; 95% CI 0.70, 0.78) and hospitalizations (HR 0.77; 95% CI 0.73, 0.81) compared to no use.

conclusionsClinicians can assist in the improved management of their multimorbid patients' health by treating depression among patients with COPD and monitoring and encouraging adherence to the regimens they prescribe.

Indexed as

Drug MonitoringAgedAged, 80 and overAntidepressive AgentsDepressionDepressive DisorderEmergency Service, HospitalFemaleHospitalizationHumansMaleMiddle AgedOutcome Assessment, Health CarePatient Acceptance of Health CarePulmonary Disease, Chronic ObstructiveRetrospective StudiesAntidepressive AgentsChronic obstructive pulmonary diseaseDepressionHealthcare utilizationMedication adherence

Identifiers

PMID28732836
PMCPMC5607946

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.